Plus, a beaten-down fintech stock with a favorable risk-reward profile, our Goldman Sachs-backed bull thesis, and Morgan Stanley’s 125% upside data center pick.
Feb 14, 2026
Sep 26, 2026
•
1 min read
Plus, a precision medicine company betting on human genetics....
Sep 19, 2026
Plus, a Top 1% analyst's Street-high edge-AI call...
Sep 12, 2026
Plus, the largest US gas producer at a peer discount...